Cargando…

A system pharmacology Boolean network model for the TLR4-mediated inflammatory response in early sepsis

Sepsis is a life-threatening condition driven by the dysregulation of the host immune response to an infection. The complex and interacting mechanisms underlying sepsis remain not fully understood. By integrating prior knowledge from literature using mathematical modelling techniques, we aimed to ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Feiyan, Aulin, Linda B. S., Kossen, Sebastiaan S. A., Cathalina, Julius, Bremmer, Marlotte, Foks, Amanda C., van der Graaf, Piet H., Moerland, Matthijs, van Hasselt, Johan G. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649476/
https://www.ncbi.nlm.nih.gov/pubmed/36261775
http://dx.doi.org/10.1007/s10928-022-09828-6
_version_ 1784827804252110848
author Liu, Feiyan
Aulin, Linda B. S.
Kossen, Sebastiaan S. A.
Cathalina, Julius
Bremmer, Marlotte
Foks, Amanda C.
van der Graaf, Piet H.
Moerland, Matthijs
van Hasselt, Johan G. C.
author_facet Liu, Feiyan
Aulin, Linda B. S.
Kossen, Sebastiaan S. A.
Cathalina, Julius
Bremmer, Marlotte
Foks, Amanda C.
van der Graaf, Piet H.
Moerland, Matthijs
van Hasselt, Johan G. C.
author_sort Liu, Feiyan
collection PubMed
description Sepsis is a life-threatening condition driven by the dysregulation of the host immune response to an infection. The complex and interacting mechanisms underlying sepsis remain not fully understood. By integrating prior knowledge from literature using mathematical modelling techniques, we aimed to obtain a deeper mechanistic insight into sepsis pathogenesis and to evaluate promising novel therapeutic targets, with a focus on Toll-like receptor 4 (TLR4)-mediated pathways. A Boolean network of regulatory relationships was developed for key immune components associated with sepsis pathogenesis after TLR4 activation. Perturbation analyses were conducted to identify therapeutic targets associated with organ dysfunction or antibacterial activity. The developed model consisted of 42 nodes and 183 interactions. Perturbation analyses suggest that over-expression of tumour necrosis factor alpha (TNF-α) or inhibition of soluble receptor sTNF-R, tissue factor, and inflammatory cytokines (IFN-γ, IL-12) may lead to a reduced activation of organ dysfunction related endpoints. Over-expression of complement factor C3b and C5b led to an increase in the bacterial clearance related endpoint. We identified that combinatory blockade of IFN-γ and IL-10 may reduce the risk of organ dysfunction. Finally, we found that combining antibiotic treatment with IL-1β targeted therapy may have the potential to decrease thrombosis. In summary, we demonstrate how existing biological knowledge can be effectively integrated using Boolean network analysis for hypothesis generation of potential treatment strategies and characterization of biomarker responses associated with the early inflammatory response in sepsis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10928-022-09828-6.
format Online
Article
Text
id pubmed-9649476
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-96494762022-11-15 A system pharmacology Boolean network model for the TLR4-mediated inflammatory response in early sepsis Liu, Feiyan Aulin, Linda B. S. Kossen, Sebastiaan S. A. Cathalina, Julius Bremmer, Marlotte Foks, Amanda C. van der Graaf, Piet H. Moerland, Matthijs van Hasselt, Johan G. C. J Pharmacokinet Pharmacodyn Original Paper Sepsis is a life-threatening condition driven by the dysregulation of the host immune response to an infection. The complex and interacting mechanisms underlying sepsis remain not fully understood. By integrating prior knowledge from literature using mathematical modelling techniques, we aimed to obtain a deeper mechanistic insight into sepsis pathogenesis and to evaluate promising novel therapeutic targets, with a focus on Toll-like receptor 4 (TLR4)-mediated pathways. A Boolean network of regulatory relationships was developed for key immune components associated with sepsis pathogenesis after TLR4 activation. Perturbation analyses were conducted to identify therapeutic targets associated with organ dysfunction or antibacterial activity. The developed model consisted of 42 nodes and 183 interactions. Perturbation analyses suggest that over-expression of tumour necrosis factor alpha (TNF-α) or inhibition of soluble receptor sTNF-R, tissue factor, and inflammatory cytokines (IFN-γ, IL-12) may lead to a reduced activation of organ dysfunction related endpoints. Over-expression of complement factor C3b and C5b led to an increase in the bacterial clearance related endpoint. We identified that combinatory blockade of IFN-γ and IL-10 may reduce the risk of organ dysfunction. Finally, we found that combining antibiotic treatment with IL-1β targeted therapy may have the potential to decrease thrombosis. In summary, we demonstrate how existing biological knowledge can be effectively integrated using Boolean network analysis for hypothesis generation of potential treatment strategies and characterization of biomarker responses associated with the early inflammatory response in sepsis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10928-022-09828-6. Springer US 2022-10-19 2022 /pmc/articles/PMC9649476/ /pubmed/36261775 http://dx.doi.org/10.1007/s10928-022-09828-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Paper
Liu, Feiyan
Aulin, Linda B. S.
Kossen, Sebastiaan S. A.
Cathalina, Julius
Bremmer, Marlotte
Foks, Amanda C.
van der Graaf, Piet H.
Moerland, Matthijs
van Hasselt, Johan G. C.
A system pharmacology Boolean network model for the TLR4-mediated inflammatory response in early sepsis
title A system pharmacology Boolean network model for the TLR4-mediated inflammatory response in early sepsis
title_full A system pharmacology Boolean network model for the TLR4-mediated inflammatory response in early sepsis
title_fullStr A system pharmacology Boolean network model for the TLR4-mediated inflammatory response in early sepsis
title_full_unstemmed A system pharmacology Boolean network model for the TLR4-mediated inflammatory response in early sepsis
title_short A system pharmacology Boolean network model for the TLR4-mediated inflammatory response in early sepsis
title_sort system pharmacology boolean network model for the tlr4-mediated inflammatory response in early sepsis
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649476/
https://www.ncbi.nlm.nih.gov/pubmed/36261775
http://dx.doi.org/10.1007/s10928-022-09828-6
work_keys_str_mv AT liufeiyan asystempharmacologybooleannetworkmodelforthetlr4mediatedinflammatoryresponseinearlysepsis
AT aulinlindabs asystempharmacologybooleannetworkmodelforthetlr4mediatedinflammatoryresponseinearlysepsis
AT kossensebastiaansa asystempharmacologybooleannetworkmodelforthetlr4mediatedinflammatoryresponseinearlysepsis
AT cathalinajulius asystempharmacologybooleannetworkmodelforthetlr4mediatedinflammatoryresponseinearlysepsis
AT bremmermarlotte asystempharmacologybooleannetworkmodelforthetlr4mediatedinflammatoryresponseinearlysepsis
AT foksamandac asystempharmacologybooleannetworkmodelforthetlr4mediatedinflammatoryresponseinearlysepsis
AT vandergraafpieth asystempharmacologybooleannetworkmodelforthetlr4mediatedinflammatoryresponseinearlysepsis
AT moerlandmatthijs asystempharmacologybooleannetworkmodelforthetlr4mediatedinflammatoryresponseinearlysepsis
AT vanhasseltjohangc asystempharmacologybooleannetworkmodelforthetlr4mediatedinflammatoryresponseinearlysepsis
AT liufeiyan systempharmacologybooleannetworkmodelforthetlr4mediatedinflammatoryresponseinearlysepsis
AT aulinlindabs systempharmacologybooleannetworkmodelforthetlr4mediatedinflammatoryresponseinearlysepsis
AT kossensebastiaansa systempharmacologybooleannetworkmodelforthetlr4mediatedinflammatoryresponseinearlysepsis
AT cathalinajulius systempharmacologybooleannetworkmodelforthetlr4mediatedinflammatoryresponseinearlysepsis
AT bremmermarlotte systempharmacologybooleannetworkmodelforthetlr4mediatedinflammatoryresponseinearlysepsis
AT foksamandac systempharmacologybooleannetworkmodelforthetlr4mediatedinflammatoryresponseinearlysepsis
AT vandergraafpieth systempharmacologybooleannetworkmodelforthetlr4mediatedinflammatoryresponseinearlysepsis
AT moerlandmatthijs systempharmacologybooleannetworkmodelforthetlr4mediatedinflammatoryresponseinearlysepsis
AT vanhasseltjohangc systempharmacologybooleannetworkmodelforthetlr4mediatedinflammatoryresponseinearlysepsis